Lu S - Search Results

1

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells.

Yuan H, Li ZM, Shao J, Ji WX, Xia W, Lu S. Yuan H, et al. Among authors: lu s. J Exp Clin Cancer Res. 2017 May 30;36(1):72. doi: 10.1186/s13046-017-0534-0. J Exp Clin Cancer Res. 2017. PMID: 28558758 Free PMC article.

2

Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.

Lu S, Zhang J, Zhou Z, Liao ML, He WZ, Zhou XY, Li ZM, Xiang JQ, Wang JJ, Chen HQ. Lu S, et al. Oncol Rep. 2008 Sep;20(3):581-7. Oncol Rep. 2008. PMID: 18695909

3

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Li Z, et al. Among authors: lu j, lu s. J Thorac Oncol. 2009 Jun;4(6):702-9. doi: 10.1097/JTO.0b013e3181a5269d. J Thorac Oncol. 2009. PMID: 19404215 Free article.

4

Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.

Zhang YF, Chen ZW, Lu S. Zhang YF, et al. Among authors: lu s. Chin Med J (Engl). 2009 Oct 20;122(20):2472-6. Chin Med J (Engl). 2009. PMID: 20079162

5

Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.

Niu X, Chen Z, Shen S, Liu Y, Zhou D, Zhang J, Li Z, Yu Y, Liao M, Lu S, He L. Niu X, et al. Among authors: lu s. J Thorac Oncol. 2010 May;5(5):658-66. doi: 10.1097/JTO.0b013e3181d5e447. J Thorac Oncol. 2010. PMID: 20234319 Free article.

6

Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosis.

Chen Z, Yu Y, Fu D, Li Z, Niu X, Liao M, Lu S. Chen Z, et al. Among authors: lu s. Cell Biochem Funct. 2010 Jun;28(4):249-57. doi: 10.1002/cbf.1634. Cell Biochem Funct. 2010. PMID: 20517887

7

A cost-effectiveness analysis of docetaxel versus pemetrexed in second-line chemotherapy for stage IIIb or IV non-small cell lung cancer in China.

Yu YF, Chen ZW, Zhou Z, Song ZB, Li ZM, Jian H, Zhang YF, Lu S. Yu YF, et al. Among authors: lu s. Chemotherapy. 2010;56(6):472-7. doi: 10.1159/000321016. Epub 2010 Nov 23. Chemotherapy. 2010. PMID: 21099219

8

Third-line therapy for advanced non-small-cell lung cancer patients: feasible drugs for feasible patients.

Song Z, Yu Y, Chen Z, Lu S. Song Z, et al. Among authors: lu s. Med Oncol. 2011 Dec;28 Suppl 1:S605-12. doi: 10.1007/s12032-010-9753-3. Epub 2010 Nov 30. Med Oncol. 2011. PMID: 21116876

9

Effect of ubiquitin carboxy-terminal hydrolase 37 on apoptotic in A549 cells.

Chen Z, Niu X, Li Z, Yu Y, Ye X, Lu S, Chen Z. Chen Z, et al. Among authors: lu s. Cell Biochem Funct. 2011 Mar;29(2):142-8. doi: 10.1002/cbf.1734. Epub 2011 Feb 1. Cell Biochem Funct. 2011. PMID: 21287580

10

The effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studies.

Chen Z, Li Z, Niu X, Ye X, Yu Y, Lu S, Chen Z. Chen Z, et al. Among authors: lu s. Mutagenesis. 2011 May;26(3):437-46. doi: 10.1093/mutage/ger002. Epub 2011 Mar 14. Mutagenesis. 2011. PMID: 21402622

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,212 results

Search Page

Filters